1998
DOI: 10.1016/s0378-1119(98)00094-8
|View full text |Cite
|
Sign up to set email alerts
|

A human homolog of the yeast CDC7 gene is overexpressed in some tumors and transformed cell lines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
47
0
2

Year Published

2002
2002
2017
2017

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 65 publications
(50 citation statements)
references
References 21 publications
1
47
0
2
Order By: Relevance
“…In addition, the protein kinase CDC7, which is involved in regulating coupling cell-cycle regulation and genome duplication, is overexpressed highly in T265 cells. This is consistent with data implicating overexpression of CDC7 in hyper-proliferation and neoplastic transformation in a range of tumor types (Hess et al, 1998).…”
Section: Cell Cyclesupporting
confidence: 92%
“…In addition, the protein kinase CDC7, which is involved in regulating coupling cell-cycle regulation and genome duplication, is overexpressed highly in T265 cells. This is consistent with data implicating overexpression of CDC7 in hyper-proliferation and neoplastic transformation in a range of tumor types (Hess et al, 1998).…”
Section: Cell Cyclesupporting
confidence: 92%
“…Human Cdc7 is overexpressed in many transformed cell lines as well as in many tumor specimens, but this overexpression does not always correlate with hyperproliferation (69). It is possible that huCdc7 overexpression is associated with neoplastic transformation.…”
Section: A 63-bp Promoter Dna Segment Highly Conserved Between Human mentioning
confidence: 99%
“…Overexpression of Cdc7-ASK occurs in various types of cancer (Hess et al 1998;Nambiar et al 2007;Bonte et al 2008;Clarke et al 2009;Kulkarni et al 2009) and often correlates with poor prognosis, suggesting that deregulated Cdc7 kinase activity may promote survival of cancer cells and tumor progression. Recently, some small molecule inhibitors of Cdc7 kinase activity have been developed and are being tested in clinical trials as candidate anti-cancer drugs (Ito et al 2008;Montagnoli et al 2008;Vanotti et al 2008;Ermoli et al 2009).…”
mentioning
confidence: 99%